PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826FA2VG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $79,248
Award facts
- Contract value 100% obligated
- $79,248.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $79,248.40 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This non-set-aside contract was competitively awarded on December 22, 2025, with an ultimate completion date of December 23, 2025, and operates under a firm fixed-price arrangement. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
AmerisourceBergen Drug Corp serves critical federal medical procurement needs through its established relationship with the Defense Logistics Agency and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates consistent capability to fulfill competitive procurements across diverse medical supply categories, ranging from diabetes and neurological medications to pain management pharmaceuticals and specialized medical supplies. This delivery order reflects the company's ongoing role as a major vendor within the DLA's pharmaceutical procurement strategy, which is transitioning toward the Pharmaceutical Prime Vendor Global Program Generation V with multiple regional award vehicles planned across different contractors.
Quick answers
Who was awarded contract SPE2D826FA2VG?
SPE2D826FA2VG was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on December 22, 2025.
How much is contract SPE2D826FA2VG worth?
The government has obligated $79,248 on SPE2D826FA2VG.
Is contract SPE2D826FA2VG an order under another contract?
Yes. SPE2D826FA2VG is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D826FA2VG competed?
The extent of competition for SPE2D826FA2VG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award